Sign up

Topic-specific electronic newsletters

Screenshot of 'News From PATH' e-newsletter.

In addition to our topic-specific e-newsletters, you can sign up for general News From PATH updates on our programmatic activities.

In addition to our News From PATH general email updates for partners and colleagues, PATH offers a number of topic-specific e-newsletters. Find out how to sign up below.

3D News: Perspectives on Defeating Diarrheal Disease

DefeatDD.org’s 3D News provides news and views for advocates, program implementers, policymakers, and anyone interested in the growing momentum for defeating the second leading killer of children worldwide. The newsletter offers the latest news on interventions and solutions, profiles of partners and success stories, summaries of recently published reports, upcoming events, and more.

A Healthy Dose, quarterly updates on our drug development work

A Healthy Dose from PATH’s Drug Development program gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development.

HPVflash, a news bulletin on cervical cancer

HPVflash is an email news bulletin that disseminates useful cervical cancer prevention information, including updates on vaccines against the human papillomavirus, to interested persons worldwide. HPVflash emails are emailed only a few times a year.

Innovation for Global Health

Innovation for Global Health is a monthly newsletter published by the Global Health Technologies Coalition (GHTC). The newsletter includes updates on the latest in global health research and product development, with a focus on activities by US Congress, US federal agencies, the global health and development community, and GHTC members.

Introduction Planning Update, periodic news about the introduction of depo-subQ in Uniject

Introduction Planning Update is a periodic newsletter intended to share information with partners, advisors, and stakeholders of PATH’s Planning for Introduction of depo-subQ provera 104™ in the Uniject™ Injection System (depo-subQ in Uniject) project. Each issue contains updates on research, product registration, and introduction planning, and also provides information about related resources.

InterCambios Monthly

This monthly update provides information to InterCambios allies about gender-based violence (GBV) research, media articles about violence, happenings in the field, and GBV-related resources, events, and opportunities. InterCambios brings together people and organizations working to respond to GBV, using an approach grounded in public health and human rights.

InterCambios Newsletter

This newsletter serves to keep advocates and professionals informed of the activities of the InterCambios Alliance and our partners in Latin America. InterCambios brings together people and organizations working to respond to gender-based violence, using an approach grounded in public health and human rights. All issues are available in Spanish; selected issues are also available in English.

Making Malaria History, a periodic update on our malaria control partnership

The Making Malaria History newsletter provides updates on the latest malaria research and news, provides advocates with timely data and resources, and shares evidence and field tools currently being used in malaria-endemic countries. Submissions and suggestions for articles are encouraged. To contact us, please email malariainform@path.org.

MVI Update, news from the PATH Malaria Vaccine Initiative

The Malaria Vaccine Initiative (MVI) provides news and updates to collaborators and partners through the MVI Update. Each issue opens with a letter from the director and provides articles about MVI’s work in malaria vaccine development and in preparing for vaccine availability and accessibility.

MVP News Digest, a quarterly update from the Meningitis Vaccine Project

MVP News Digest provides a quarterly update of activities at the Meningitis Vaccine Project (MVP), a partnership between the World Health Organization and PATH. MVP works to eliminate epidemic meningitis as a public health problem in sub-Saharan Africa through the advancement of a meningococcal conjugate vaccine. The digest offers news on vaccine development, clinical and surveillance activities, epidemiologic research, and vaccine introduction.

Op.ti.mize, a quarterly update from Project Optimize

The Op.ti.mize quarterly e-newsletter highlights advances and innovations in health care logistics, technologies, and policy. Developed by Project Optimize, a collaboration between the World Health Organization and PATH, this newsletter provides an overview of the project’s current activities and areas of focus.

RotaFlash, breaking news on rotavirus disease and vaccines

RotaFlash provides breaking scientific news on rotavirus disease and vaccines and updates on progress toward increasing global access to vaccines against rotavirus, the leading cause of severe and fatal diarrhea in young children worldwide.

Vaccines for the Future, a quarterly update from PATH’s vaccine development program

Vaccines for the Future provides quarterly updates on our efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world populations, pneumonia (pneumococcal disease) and diarrheal disease (rotavirus, Shigella, enterotoxigenic Escherichia coli), as well as new vaccines for the global population against influenza, meningitis, and respiratory syncytial virus. It includes updates on our progress, partnerships, and specific activities.

Vaccine Technologies News and Updates

Vaccine Technologies News and Updates provides timely, periodic briefings on our work to advance innovative technologies that help to improve vaccine products and the way they are delivered, especially in remote settings with limited access to health facilities and refrigeration equipment. The e-newsletter offers public health colleagues, technology partners, and other stakeholders a variety of scientific updates, programmatic announcements, upcoming event listings, and additional resources for further reading.

PATH recognizes and respects the privacy of our online visitors. For more information, please see our privacy policy. You can opt out of our e-newsletters at any time by unsubscribing individually or by sending a request to info@path.org.

Photo: PATH.